Groupe PARIMA

Canada
Semi-solids & Liquids Oral Solid Dose
Program data pending ClinicalTrials.gov matching
Profiled
Not yet scored
✓ FDA Inspections (1) ○ Clinical Trials ○ SEC Filings ○ Press ○ EMA GMP ○ MHRA GMP ✓ HC GMP (3)

Quick Facts: Groupe PARIMA

Signal Score
Profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed. How scoring works
Headquarters
Canada
Website
Modalities
Semi-solids & Liquids, Oral Solid Dose
Active Programs
No ClinicalTrials.gov matches confirmed
Data Sources
FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring

About Groupe PARIMA

Groupe PARIMA is a contract development and manufacturing organization (CDMO). Capabilities: Semi-solids & Liquids, Oral Solid Dose. 1 manufacturing site registered with the U.S. FDA and Health Canada. Website: https://www.groupeparima.com

Signal Score

Profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed. How scoring works

Groupe PARIMA FDA Inspection History

2023-08
NAI VAI OAI
Date Site Type Observations Classification
2023-08-25
Groupe Parima Inc.
Saint-Laurent Company-level
Drug Quality Assurance Yes Voluntary Action Indicated (VAI)
Source: FDA Data Dashboard · Retrieved Oct 31, 2026

Groupe PARIMA FDA 483 Findings 6 observations · 2023-08-25 → 2023-08-25 ?

By subsystem

  • Documentation & Records 2 (33.3%)
  • Other 1 (16.7%)
  • Laboratory Controls 1 (16.7%)
  • Equipment & Facilities 1 (16.7%)
  • Data Integrity 1 (16.7%)

By severity

  • 5 — Critical: 1
  • 3 — Moderate: 1
  • 2 — Minor: 4
  • Repeat observations: 0

Most severe findings

  • Critical (5) Data Integrity 2023-08-25 21 CFR 211.68(b)
    Computer control of master formula records

    "Appropriate controls are not exercised over computers or related systems to assure that changes in master production and control records or other records are instituted only by authorized personnel."

  • Moderate (3) Laboratory Controls 2023-08-25 21 CFR 211.160(a)
    Following/documenting laboratory controls

    "Established laboratory control mechanisms are not documented at the time of performance."

  • Minor (2) Other 2023-08-25 21 CFR 211.125(a)
    Strict control not exercised over labeling issued

    "Strict control is not exercised over labeling issued for use in drug product labeling operations."

Hiring Activity Beta

Built from public job postings when a company's own roles can be read. Job postings are signals, not statements by the company; each one below links to the original. How we collect this
No hiring data yet. We haven't found a public jobs feed for this company.
Source: public careers pages · Checked Oct 30, 2026

Frequently Asked Questions About Groupe PARIMA

How many FDA inspections does Groupe PARIMA have on record?
CDMO Signal tracks 1 FDA inspection for Groupe PARIMA, sourced from the FDA inspection database. See the full inspection history above.
Has Groupe PARIMA received an FDA warning letter?
CDMO Signal has no FDA warning letters on record for Groupe PARIMA.
Does Groupe PARIMA have a CDMO Signal Score?
Not yet. Groupe PARIMA is profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed.
Evaluating Groupe PARIMA for a manufacturing program?
Use the free AI matchmaker to compare Groupe PARIMA against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.

Similar CDMOs

Halo Pharmaceutical Canada
Mirabel, Quebec, Canada
Oral Solid Dose, Semi-solids & Liquids
Pierre Fabre CDMO
Castres, France
Oral Solid Dose, Finished Dosage Forms, Non-sterile Liquids, Semi-solids & Liquids, Small Molecule API, High-Potency APIs, Packaging & Labeling
Vetio Animal Health
United States
Oral Solid Dose, Semi-solids & Liquids, Sterile Fill-Finish
Contract Pharmacal Corp.
Hauppauge, New York, USA
Oral Solid Dose, Semi-solids & Liquids
Fourrts (India) Laboratories
Chennai, India
Oral Solid Dose, Semi-solids & Liquids

Compare Groupe PARIMA with another CDMO

Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.
Compare side-by-side
See two CDMOs' scoring, inspection history, and clinical footprint next to each other.
Open comparison →
Run a sourcing search
Describe your program's requirements — Signal matches CDMOs against FDA, EMA/MHRA, ClinicalTrials.gov and capacity signals.
Search for a CDMO →
Get updates on Groupe PARIMA
Get an email when a CDMO on this list has a new FDA inspection, GMP certificate, or scoring change.